3481:TWSEInnolux Corp. Analysis
Data as of 2026-05-14 - not real-time
NT$35.40
Latest Price
8/10Risk
Risk Level: High
Executive Summary
Innolux is riding a strong bullish technical backdrop, with moving averages aligned in a positive hierarchy and a bullish MACD crossover confirming upward momentum. However, the RSI has surged into overbought territory, suggesting a near‑term pull‑back risk. The stock trades near its recent high, but the support level remains comfortably above the lower bound of its 52‑week range, providing a cushion against downside.
Fundamentally, the company faces a stark valuation mismatch: its price‑earnings multiple dwarfs the industry average, while margins are thin and cash conversion is negligible. Revenue growth is respectable, yet profitability metrics are near zero, raising doubts about sustainable earnings. The dividend yield appears attractive, but the underlying earnings base and zero return on equity cast serious doubt on its long‑term sustainability.
Fundamentally, the company faces a stark valuation mismatch: its price‑earnings multiple dwarfs the industry average, while margins are thin and cash conversion is negligible. Revenue growth is respectable, yet profitability metrics are near zero, raising doubts about sustainable earnings. The dividend yield appears attractive, but the underlying earnings base and zero return on equity cast serious doubt on its long‑term sustainability.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Bullish MACD and moving‑average alignment
- RSI indicating overbought conditions
- Proximity to recent resistance level
Medium Term
1–3 yearsNeutral
Model confidence: 5/10
Key Factors
- Revenue growth offset by thin margins
- High valuation relative to peers
- Dividend yield with questionable sustainability
Long Term
> 3 yearsCautious
Model confidence: 4/10
Key Factors
- Persistently low profitability and cash flow
- Valuation disconnect from earnings
- Competitive pressure in the display panel market
Key Metrics & Analysis
Financial Health
Revenue Growth19.20%
Profit Margin0.39%
P/E Ratio1180.0
Debt/Equity24.69
P/B Ratio1.3
Industry P/E38.8
Technical Analysis
TrendBullish
RSI70.9
SupportNT$22.95
ResistanceNT$38.65
MA 20NT$27.75
MA 50NT$27.03
MA 200NT$18.43
MACDBullish
VolumeIncreasing
Fear & Greed Index89.48
Valuation
Target PriceNT$19.76
Upside/Downside-44.19%
GradeOvervalued
TypeBlend
Dividend Yield2.67%
Risk Assessment
Beta0.49
Volatility71.39%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.